BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22134402)

  • 1. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
    Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
    Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
    Aoun T; Harissi-Dagher M
    J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
    Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
    Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
    Robert MC; Pomerleau V; Harissi-Dagher M
    Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boston keratoprosthesis outcomes and complications.
    Chew HF; Ayres BD; Hammersmith KM; Rapuano CJ; Laibson PR; Myers JS; Jin YP; Cohen EJ
    Cornea; 2009 Oct; 28(9):989-96. PubMed ID: 19724214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.
    Ali MH; Dikopf MS; Finder AG; Aref AA; Vajaranant T; de la Cruz J; Cortina MS
    Cornea; 2018 May; 37(5):602-608. PubMed ID: 29474296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort.
    Senthil S; Mohamed A; Shanbhag SS; Durgam SS; Bagga B; Sangwan VS; Basu S
    Cornea; 2022 May; 41(5):552-561. PubMed ID: 35383615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate-term Visual Outcomes and Complications of Type 1 Boston Keratoprosthesis With and Without Glaucoma Surgery.
    AlHilali S; Martinez-Osorio H; AlObaida I; Jomar D; AlZendi N; AlJassar F; AlShahwan S; Ahmad A; Malik R; Vargas J
    Cornea; 2022 Aug; 41(8):950-957. PubMed ID: 35184127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis.
    Crnej A; Paschalis EI; Salvador-Culla B; Tauber A; Drnovsek-Olup B; Shen LQ; Dohlman CH
    Cornea; 2014 Apr; 33(4):349-54. PubMed ID: 24531120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.